Yosuke Mizuno
- Cancer Research top 5%
- MicroRNA in disease regulation 3
- Molecular Biology top 10%
- Pluripotent Stem Cells Research 10
- CRISPR and Genetic Engineering 8
- Mitochondrial Function and Pathology 4
- Epigenetics and DNA Methylation 3
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders 4
-
- Reproductive System and Pregnancy 3
- T-cell and B-cell Immunology 3
- Obstetrics and Gynecology top 10%
- Co-authors
- Yasushi OkazakiYoshimi TokuzawaAkihiko OkudaTatsuo SudaYasumitsu KondohTakenobu KatagiriToru FukudaHideo Tashiro
- Journals
- Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Yosuke Mizuno
33 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 88
- Cancer Research 404
- Molecular Biology 692
- Clinical Biochemistry 49
- Immunology 144
- Obstetrics and Gynecology 53
Countries citing papers authored by Yosuke Mizuno
This map shows the geographic impact of Yosuke Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosuke Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosuke Mizuno more than expected).
Fields of papers citing papers by Yosuke Mizuno
This network shows the impact of papers produced by Yosuke Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosuke Mizuno. The network helps show where Yosuke Mizuno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yosuke Mizuno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 2 | |
| 5 | 2020 | 22 | |
| 6 | 2020 | 16 | |
| 7 | 2019 | 33 | |
| 8 | 2019 | 8 | |
| 9 | 2017 | 9 | |
| 10 | 2017 | 12 | |
| 11 | 2017 | 42 | |
| 12 | 2016 | 59 | |
| 13 | 2015 | 24 | |
| 14 | 2014 | 43 | |
| 15 | 2013 | 8 | |
| 16 | 2012 | 22 | |
| 17 | 2011 | 55 | |
| 18 | 2010 | 41 | |
| 19 | 2008 | 66 | |
| 20 | 2008 | 251 |
About Yosuke Mizuno
Yosuke Mizuno is a scholar working on Clinical Biochemistry, Complementary and Manual Therapy and Molecular Biology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (10 papers), CRISPR and Genetic Engineering (8 papers), Mitochondrial Function and Pathology (4 papers), Metabolism and Genetic Disorders (4 papers), MicroRNA in disease regulation (3 papers), Reproductive System and Pregnancy (3 papers), Epigenetics and DNA Methylation (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Cancer Research (404 citations), Molecular Biology (692 citations) and Clinical Biochemistry (49 citations). Yosuke Mizuno has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yasushi Okazaki, Yoshimi Tokuzawa, Akihiko Okuda, Tatsuo Suda, Yasumitsu Kondoh, Takenobu Katagiri, Toru Fukuda, Hideo Tashiro, Ken Yagi and Masayoshi Maruyama. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.